MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line

MLA

Juliana A. Camargo, et al. “MicroRNA-23b and MicroRNA-27b plus Flutamide Treatment Enhances Apoptosis Rate and Decreases CCNG1 Expression in a Castration-Resistant Prostate Cancer Cell Line.” Tumor Biology, vol. 40, Nov. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2419a42e5dfb3c2b47dad962c685bc8c&authtype=sso&custid=ns315887.

APA

Juliana A. Camargo, Vanessa Ribeiro Guimarães, Nayara I. Viana, Katia Rm Leite, Ruan Pimenta, Jose Pontes, Sabrina T. Reis, Gabriela Q. Amaral, Denis R. Morais, Miguel Srougi, William C. Nahas, & Rubens Park. (2018). MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line. Tumor Biology, 40.

Chicago

Juliana A. Camargo, Vanessa Ribeiro Guimarães, Nayara I. Viana, Katia Rm Leite, Ruan Pimenta, Jose Pontes, Sabrina T. Reis, et al. 2018. “MicroRNA-23b and MicroRNA-27b plus Flutamide Treatment Enhances Apoptosis Rate and Decreases CCNG1 Expression in a Castration-Resistant Prostate Cancer Cell Line.” Tumor Biology 40 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2419a42e5dfb3c2b47dad962c685bc8c&authtype=sso&custid=ns315887.